{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:22:11Z","timestamp":1790785331479,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"International Science and Technology Cooperation Program of China","award":["2014DFA31980"],"award-info":[{"award-number":["2014DFA31980"]}]},{"name":"Shaanxi Provincial Key Project","award":["2017ZDXM-SF-058"],"award-info":[{"award-number":["2017ZDXM-SF-058"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601498"],"award-info":[{"award-number":["81601498"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81600562"],"award-info":[{"award-number":["81600562"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Light-chain (AL) amyloidosis is the most common type of systemic amyloidosis with poor prognosis. Currently, the predictors of cardiac involvement and prognostic staging systems are primarily based on conventional echocardiography and serological biomarkers. We used three-dimensional speckle tracking echocardiography (STE-3D) measurements of strain, hypothesizing that it could detect cardiac involvement and aid in prediction of mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analysed 74 consecutive patients with biopsy-proven AL amyloidosis. Among them, 42 showed possible cardiac involvement and 32 without cardiac involvement. LV global longitudinal strain (GLS), global radial strain, global circumferential strain and global area strain (GAS) measurements were obtained.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The GLS and GAS were considered significant predictors of cardiac involvement. The cut-off values discriminating cardiac involvement were 16.10% for GLS, 32.95% for GAS. During the median follow-up of 12.5\u00a0months (interquartile range 4\u201325\u00a0months), 20 (27%) patients died. For the Cox proportional model survival analysis, heart rate, cardiac troponin T, NT-proBNP levels, E\/e\u2019, GLS, and GAS were univariate predictors of death. Multivariate Cox model showed that GLS\u2009\u2264\u200914.78% and cardiac troponin T\u2009\u2265\u20090.049\u00a0mg\/l levels were independent predictors of survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>STE-3D measurements of LV myocardial mechanics could detect cardiac involvement in patients with AL amyloidosis; GLS and cardiac biomarkers can provided prognostic information for mortality prediction.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-01856-3","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T07:02:57Z","timestamp":1611212577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters"],"prefix":"10.1186","volume":"21","author":[{"given":"Changhui","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiren","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"issue":"7","key":"1856_CR1","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","volume":"79","author":"RA Kyle","year":"1992","unstructured":"Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O\u2019Fallon WM, Kurland LT. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 1992;79(7):1817\u201322.","journal-title":"Blood"},{"issue":"5","key":"1856_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-018-0080-9","volume":"8","author":"MA Gertz","year":"2018","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018. Blood Cancer J. 2018;8(5):1\u20138.","journal-title":"Blood Cancer J"},{"issue":"14","key":"1856_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","volume":"103","author":"AD Martha Grogan","year":"2017","unstructured":"Martha Grogan AD, Gertz MA. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart. 2017;103(14):1065\u201372.","journal-title":"Heart"},{"issue":"4","key":"1856_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/0002-9149(75)90891-7","volume":"36","author":"C Chew","year":"1975","unstructured":"Chew C, Ziady GM, Raphael MJ, Oakley CM. The functional defect in amyloid heart disease. The \u201cstiff heart\u201d syndrome. Am J Cardiol. 1975;36(4):438\u201344.","journal-title":"Am J Cardiol"},{"issue":"13","key":"1856_CR5","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","volume":"120","author":"C Rapezzi","year":"2009","unstructured":"Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, Ciliberti P, Pastorelli F, Biagini E, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation. 2009;120(13):1203\u201312.","journal-title":"Circulation"},{"issue":"14","key":"1856_CR6","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1182\/blood-2010-02-267708","volume":"116","author":"AV Kristen","year":"2010","unstructured":"Kristen AV, Giannitsis E, Lehrke S, Hegenbart U, Konstandin M, Lindenmaier D, Merkle C, Hardt S, Schnabel PA, Rocken C, et al. Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay. Blood. 2010;116(14):2455\u201361.","journal-title":"Blood"},{"issue":"14","key":"1856_CR7","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","volume":"29","author":"G Merlini","year":"2011","unstructured":"Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(14):1924\u201333.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"1856_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.amjmed.2011.04.013","volume":"124","author":"P Kapoor","year":"2011","unstructured":"Kapoor P, Thenappan T, Singh E, Kumar S, Greipp PR. Cardiac amyloidosis: a practical approach to diagnosis and management. Am J Med. 2011;124(11):1006\u201315.","journal-title":"Am J Med"},{"issue":"3","key":"1856_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3109\/13506129709014387","volume":"4","author":"P Westermark","year":"2009","unstructured":"Westermark P. Classification of amyloid fibril proteins and their precursors: an ongoing discussion. Amyloid-J Protein Fold Disord. 2009;4(3):216\u20138.","journal-title":"Amyloid-J Protein Fold Disord"},{"issue":"1","key":"1856_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12872-018-0952-8","volume":"18","author":"P Kyriakou","year":"2018","unstructured":"Kyriakou P, Mouselimis D, Tsarouchas A, Rigopoulos A, Bakogiannis C. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers. BMC Cardiovasc Disord. 2018;18(1):221.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"1856_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccl.2019.07.013","volume":"37","author":"KM Alexander","year":"2019","unstructured":"Alexander KM, Evangelisti A, Witteles RM. Diagnosis and treatment of cardiac amyloidosis related to plasma cell dyscrasias. Cardiol Clin. 2019;37(4):487\u201395.","journal-title":"Cardiol Clin"},{"issue":"6","key":"1856_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.echo.2010.03.027","volume":"23","author":"D Bellavia","year":"2010","unstructured":"Bellavia D, Pellikka PA, Al-Zahrani GB, Abraham TP, Dispenzieri A, Miyazaki C, Lacy M, Scott CG, Oh JK, Miller FA Jr. Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2010;23(6):643\u201352.","journal-title":"J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"issue":"19","key":"1856_CR13","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","volume":"107","author":"J Koyama","year":"2003","unstructured":"Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003;107(19):2446\u201352.","journal-title":"Circulation"},{"issue":"40","key":"1856_CR14","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1556\/OH.2012.29466","volume":"153","author":"A Nemes","year":"2012","unstructured":"Nemes A, Kalapos A, Domsik P, Forster T. Three-dimensional speckle-tracking echocardiography\u2014a further step in non-invasive three-dimensional cardiac imaging. Orv Hetil. 2012;153(40):1570\u20137.","journal-title":"Orv Hetil"},{"issue":"4","key":"1856_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","volume":"10","author":"S Barros-Gomes","year":"2017","unstructured":"Barros-Gomes S, Williams B, Nhola LF, Grogan M, Maalouf JF, Dispenzieri A, Pellikka PA, Villarraga HR. Prognosis of light chain amyloidosis with preserved LVEF: added value of 2D speckle-tracking echocardiography to the current prognostic staging system. JACC Cardiovasc Imaging. 2017;10(4):398\u2013407.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"1856_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004. Am J Hematol. 2005;79(4):319\u201328.","journal-title":"Am J Hematol"},{"issue":"9","key":"1856_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","volume":"30","author":"S Kumar","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Colby C, Laumann K, Zeldenrust SR, Leung N, Dingli D, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(9):989\u201395.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"1856_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2015;28(1):1-39.e14.","journal-title":"J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"issue":"5","key":"1856_CR19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/0735-1097(92)90385-Z","volume":"20","author":"G de Simone","year":"1992","unstructured":"de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20(5):1251\u201360.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1856_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ajh.21934","volume":"86","author":"MA Gertz","year":"2011","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol. 2011;86(2):180\u20136.","journal-title":"Am J Hematol"},{"issue":"8","key":"1856_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.recesp.2015.01.011","volume":"68","author":"JA Urbano-Moral","year":"2015","unstructured":"Urbano-Moral JA, Gangadharamurthy D, Comenzo RL, Pandian NG, Patel AR. Three-dimensional speckle tracking echocardiography in light chain cardiac amyloidosis: examination of left and right ventricular myocardial mechanics parameters. Revista espanola de cardiologia (Engl Ed). 2015;68(8):657\u201364.","journal-title":"Revista espanola de cardiologia (Engl Ed)"},{"issue":"13","key":"1856_CR22","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","volume":"112","author":"RH Falk","year":"2005","unstructured":"Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112(13):2047\u201360.","journal-title":"Circulation"},{"issue":"2","key":"1856_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/13506120902879681","volume":"16","author":"MC Porciani","year":"2009","unstructured":"Porciani MC, Lilli A, Perfetto F, Cappelli F, Massimiliano Rao C, Del Pace S, Ciaccheri M, Castelli G, Tarquini R, Romagnani L, et al. Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. 2009;16(2):63\u201370.","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"6\u20137","key":"1856_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ejheart.2007.01.012","volume":"9","author":"AV Kristen","year":"2007","unstructured":"Kristen AV, Perz JB, Schonland SO, Hegenbart U, Schnabel PA, Kristen JH, Goldschmidt H, Katus HA, Dengler TJ. Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail. 2007;9(6\u20137):617\u201324.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"1856_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.amjcard.2011.03.092","volume":"108","author":"D Liu","year":"2011","unstructured":"Liu D, Niemann M, Hu K, Herrmann S, Stork S, Knop S, Ertl G, Weidemann F. Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis. Am J Cardiol. 2011;108(4):591\u20138.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1856_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12574-015-0249-1","volume":"13","author":"F Cacciapuoti","year":"2015","unstructured":"Cacciapuoti F. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. J Echocardiogr. 2015;13(3):84\u20139.","journal-title":"J Echocardiogr"},{"issue":"4","key":"1856_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jcmg.2009.11.013","volume":"3","author":"J Koyama","year":"2010","unstructured":"Koyama J, Falk RH. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging. 2010;3(4):333\u201342.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"1856_CR28","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","volume":"129","author":"CC Quarta","year":"2014","unstructured":"Quarta CC, Solomon SD, Uraizee I, Kruger J, Longhi S, Ferlito M, Gagliardi C, Milandri A, Rapezzi C, Falk RH. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation. 2014;129(18):1840\u20139.","journal-title":"Circulation"},{"issue":"1","key":"1856_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21037\/cdt.2017.06.01","volume":"8","author":"D Muraru","year":"2018","unstructured":"Muraru D, Niero A, Rodriguez-Zanella H, Cherata D, Badano L. Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. Cardiovasc Diagn Therapy. 2018;8(1):101\u201317.","journal-title":"Cardiovasc Diagn Therapy"},{"issue":"12","key":"1856_CR30","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1111\/echo.13354","volume":"33","author":"SH Shin","year":"2016","unstructured":"Shin SH, Suh YJ, Baek YS, Lee MJ, Park SD, Kwon SW, Woo SI, Kim DH, Park KS, Kwan J. Impact of area strain by 3D speckle tracking on clinical outcome in patients after acute myocardial infarction. Echocardiography (Mount Kisco, NY). 2016;33(12):1854\u20139.","journal-title":"Echocardiography (Mount Kisco, NY)"},{"issue":"4","key":"1856_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.echo.2016.11.012","volume":"30","author":"K Broch","year":"2017","unstructured":"Broch K, de Marchi SF, Massey R, Hisdal J, Aakhus S, Gullestad L, Urheim S. Left ventricular contraction pattern in chronic aortic regurgitation and preserved ejection fraction: simultaneous stress\u2013strain analysis by three-dimensional echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2017;30(4):422-430.e422.","journal-title":"J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"key":"1856_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijcard.2018.03.088","volume":"271","author":"A Vitarelli","year":"2018","unstructured":"Vitarelli A, Lai S, Petrucci MT, Gaudio C, Capotosto L, Mangieri E, Ricci S, Germano G, De Sio S, Truscelli G, et al. Biventricular assessment of light-chain amyloidosis using 3D speckle tracking echocardiography: differentiation from other forms of myocardial hypertrophy. Int J Cardiol. 2018;271:371\u20137.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1856_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","volume":"6","author":"SM Banypersad","year":"2013","unstructured":"Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, Cox AT, Fontana M, Whelan CJ, Wechalekar AD, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging. 2013;6(1):34\u20139.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"1856_CR34","doi-asserted-by":"publisher","first-page":"H1452","DOI":"10.1152\/ajpheart.01148.2006","volume":"292","author":"M Carlsson","year":"2007","unstructured":"Carlsson M, Ugander M, Mosen H, Buhre T, Arheden H. Atrioventricular plane displacement is the major contributor to left ventricular pumping in healthy adults, athletes, and patients with dilated cardiomyopathy. Am J Physiol Heart Circul Physiol. 2007;292(3):H1452-1459.","journal-title":"Am J Physiol Heart Circul Physiol"},{"issue":"10","key":"1856_CR35","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","volume":"51","author":"H Vogelsberg","year":"2008","unstructured":"Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008;51(10):1022\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1856_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jcmg.2010.12.007","volume":"4","author":"Y Seo","year":"2011","unstructured":"Seo Y, Ishizu T, Enomoto Y, Sugimori H, Aonuma K. Endocardial surface area tracking for assessment of regional LV wall deformation with 3D speckle tracking imaging. JACC Cardiovasc Imaging. 2011;4(4):358\u201365.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"1856_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","volume":"9","author":"J Ternacle","year":"2016","unstructured":"Ternacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P, Radu C, Guendouz S, Couetil JP, Benhaiem N, et al. Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis. JACC Cardiovasc Imaging. 2016;9(2):126\u201338.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"1856_CR38","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","volume":"60","author":"SJ Buss","year":"2012","unstructured":"Buss SJ, Emami M, Mereles D, Korosoglou G, Kristen AV, Voss A, Schellberg D, Zugck C, Galuschky C, Giannitsis E, et al. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol. 2012;60(12):1067\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"1 Pt 1","key":"1856_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","volume":"13","author":"A Baggiano","year":"2020","unstructured":"Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, Gritti M, Quarta C, Knight DS, Wechalekar AD, et al. Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2020;13(1 Pt 1):69\u201380.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"1856_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.echo.2019.03.005","volume":"32","author":"PV Mo\u00f1ivas","year":"2019","unstructured":"Mo\u00f1ivas PV, Durante-Lopez A, Sanabria MT, Cubero JS, Gonz\u00e1lez-Mirelis J, Lopez-Ibor JV, Navarro Rico SM, Krsnik I, Dominguez F, Mingo AM, Hernandez-Perez FJ, Cavero G, Santos SM. Role of right ventricular strain measured by two-dimensional echocardiography in the diagnosis of cardiac amyloidosis. J Am Soc Echocardiogr. 2019;32(7):845-853.e1.","journal-title":"J Am Soc Echocardiogr"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-021-01856-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T07:05:56Z","timestamp":1611212756000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-01856-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-01856-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"assertion":[{"value":"5 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Xijing Hospital of China(KY20163160-1). All patients signed written informed consents during their hospitalization.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}